2025 KAMDA Conference
The 1st KAMDA Conference · · Reed Smith LLP, 22nd Floor, 599 Lexington Ave, New York, NY 10022
“Facing the Real Barriers: Korean Medical Device Companies' Strategic Entry into the U.S.”
Who it was for
- Korean-American medical device industry professionals
- Healthcare providers
- FDA, insurance and legal experts
- Investors and related stakeholders
Program highlights
- Expert session on U.S. FDA regulations
- Insurance and reimbursement system overview
- Sponsor presentations
- Panel discussion: strategic entry into the U.S. market
- Networking dinner and pre-event meetings
Program, October 23, 2025
Download the 2025 program| Time | Session | Speaker | Affiliation |
|---|---|---|---|
| 9:30 to 10:30 AM | Registration & Networking | ||
| 10:30 to 11:00 AM | Welcome Remark | HeaYeon Lee, Ph.D. | CEO, MARA Nanotech; Vice President, KAMDA |
| Congratulatory Remark | SeongSoo Kim | Consulate General of the Republic of Korea, New York | |
| Congratulatory Remark | SoonMahn Park | Head of Korea Health Industry Development Institute, Boston Office | |
| Congratulatory Remark | SungWoo Baek | Director, New York Global Business Center, Korea SMEs & Startups Agency | |
| Congratulatory Remark | MyeongSeon Kim | Director, Korea Venture Investment Corp., New York office | |
| 11:00 to 11:20 AM | Opening Plenary: Technology Trends and Market Status of Biosensors in U.S. | HeaYeon Lee, Ph.D. | CEO, MARA Nanotech; Conference Chair, KAMDA |
| 11:20 AM to 12:00 PM | Keynote: Significance of KAMDA Establishment & Success Case in the U.S. Market (AccessBio) | YoungHo Choi | Chairman, Access Bio; Co-Chair, KAMDA |
| 12:00 to 1:00 PM | Lunch | ||
| 1:00 to 1:40 PM | Special Session I: FDA Trends & Global Regulation Insights | Haja Sittana El Mubarak, Ph.D. | Wasela Diagnostics LLC |
| 1:40 to 2:00 PM | FDA Approval Strategies and Success Cases | ByungSik Chang, Ph.D. | CEO, Nano-Ditech; Co-Chair, KAMDA |
| 2:00 to 2:20 PM | FDA Preparation and Approval Strategy (CRO) | JungYoup Han, Ph.D. | CSO, Target Health; Treasurer, KAMDA |
| 2:20 to 2:40 PM | Appropriate Risk Allocation in the FDA World | Sung Park | Reed Smith |
| 2:40 to 2:50 PM | Coffee break | ||
| 2:50 to 3:30 PM | Special Session II: Understanding the U.S. Healthcare Insurance System (Reimbursement system) | MinSoo Seo | CEO, Taewoong Medical USA |
| 3:30 to 3:50 PM | Market Entry Strategy for the U.S. (Applications of LDT and CLIA Lab) | JungHee Cho, Ph.D. | CEO, LabG USA; Executive Secretary, KAMDA |
| 3:50 to 4:10 PM | Market Entry Strategy for the U.S. (Case Studies of U.S. Local Company Acquisitions) | Curie Choi | Director, Immunostics; Operations Committee, KAMDA |
| 4:10 to 4:30 PM | Understanding IP and Compliance | Eunjean Je | Morgan, Lewis & Bockius LLP |
| 4:30 to 5:15 PM | Sponsored Session | ||
| 5:15 to 5:30 PM | Coffee break | ||
| 5:30 to 6:30 PM | Panel: U.S. Market Entry and Medical Device Market Strategy | Moderator: HeaYeon Lee, Ph.D. | Panel: MinSoo Seo, YoungHo Choi, ByungSik Chang, JungHee Cho, JungYoup Han |
| 6:30 to 6:40 PM | Closing ceremony | ||
| 6:40 to 8:30 PM | Dinner & Networking |
Program as published by KAMDA in September 2025.
2025 supporters
- Consulate General of the Republic of Korea in New York
- KOSME (Korea SMEs and Startups Agency)
- KHIDI (Korea Health Industry Development Institute)
- Reed Smith
- Bank of Hope